Frontiers in Oncology | Cancer Molecular Targets and Therapeutics

Review

Published on 01 Apr 2025

Advancements in research on the precise eradication of cancer cells through nanophotocatalytic technology

in Cancer Molecular Targets and Therapeutics

Changyang Yao
Chensong Zhang
Dongwei Fan
Xuanhe Li
Shaofa Zhang
Daoxin Liu

Frontiers in Oncology

doi 10.3389/fonc.2025.1523444

203 views

Original Research

Published on 31 Mar 2025

Identification of MAD2L1 as a novel biomarker for hepatoblastoma through bioinformatics and machine learning approaches

in Cancer Molecular Targets and Therapeutics

Ying He
Xiwei Hao
Bin Hu
Nan Xia
Chaojin Wang
Xin Chen
Huanyu Zhang
Yuhe Duan
Qinglong Ying
Qian Dong

Frontiers in Oncology

doi 10.3389/fonc.2025.1524714

197 views

Review

Published on 31 Mar 2025

The role and regulatory mechanism of lysosome associated protein transmembrane 4β in tumors

in Cancer Molecular Targets and Therapeutics

Yuteng Yang
Yumei Li
Yaqi Wang
Xi Chen
Yisong Yao
Dongxian Li
Guohua Yu
Xicheng Song

Frontiers in Oncology

doi 10.3389/fonc.2025.1552007

128 views

Perspective

Accepted on 28 Mar 2025

Bringing Value to Cancer Research

in Cancer Molecular Targets and Therapeutics

Casey Jackson Allen
Horn M Danea
Fabrice Smieliauskas
Stephen Edge
Rachel A Greenup

Frontiers in Oncology

doi 10.3389/fonc.2025.1580575

Original Research

Accepted on 28 Mar 2025

Expression of SMURF family in pancreatic cancer and its effect on cell proliferation and migration

in Cancer Molecular Targets and Therapeutics

Lin Shi
Chen Zhang
Caoyi Li
Yuan Wang
Ke Huang
Xu Yang
Sai Zhao
Haoran Zhu
Jian Wang

Frontiers in Oncology

doi 10.3389/fonc.2025.1538335

Case Report

Published on 28 Mar 2025

Case Report: Personalized diagnosis and treatment strategies for three cases of cancer of unknown primary based on molecular testing techniques

in Cancer Molecular Targets and Therapeutics

Yao Ding
Kexue Zhou
Kaiwen Fu
Xingyun Liao
Shuanglong Xiong
Chengxiang Yang
Mingyang Hu
Guanzhong Liang
Xianghua Zeng
Yongsheng Li

Frontiers in Oncology

doi 10.3389/fonc.2025.1505271

191 views

Review

Accepted on 27 Mar 2025

Epigenetic insights into Prostate Cancer: Exploring histone modifications and their therapeutic implications

in Cancer Molecular Targets and Therapeutics

Bunty Sharma
Himanshu Shekhar
Anidrisha Sahu
Damandeep Kaur
Shafiul Haque
Hardeep Singh Tuli
Dr Himanshu Sharma
Ujjawal Sharma

Frontiers in Oncology

doi 10.3389/fonc.2025.1570193

Systematic Review

Published on 26 Mar 2025

Advances in bevacizumab in colorectal cancer: a bibliometric analysis from 2004 to 2023

in Cancer Molecular Targets and Therapeutics

Hao Chen
Yeqing Lei
Junjie Zhou
Chenhui Lv
Qijia Xuan

Frontiers in Oncology

doi 10.3389/fonc.2025.1552914

253 views

Review

Accepted on 25 Mar 2025

The Role and Clinical Significance of Tumor-Associated Macrophages in the Epithelial-Mesenchymal Transition of Lung Cancer

in Cancer Molecular Targets and Therapeutics

磊廖
Ying-Xia WANG
Su-Su Fan
Xue-Chang Wang
Xuan Zhang

Frontiers in Oncology

doi 10.3389/fonc.2025.1571583

Original Research

Accepted on 24 Mar 2025

PITX1 as a grading, prognostic and Tumor-infiltrating Immune Cells marker for chondrosarcoma: a public database-based immunoassay and tissue sample analysis

in Cancer Molecular Targets and Therapeutics

Shubiao Chen
Zikun Huang
Liu Dongchen
Ying Zhang
Weiqing Lu
Lan Hu
Jinghao Zhang
Lei Xie

Frontiers in Oncology

doi 10.3389/fonc.2025.1477649

Review

Accepted on 24 Mar 2025

The biological role and molecular mechanism of transfer RNA-derived small RNAs in tumor metastasis

in Cancer Molecular Targets and Therapeutics

Haotian Dong
Chengyuan Ye
Xiaohan Ye
Jianing Yan
Guoliang Ye
Yongfu Shao

Frontiers in Oncology

doi 10.3389/fonc.2025.1560943

Original Research

Published on 24 Mar 2025

A seven-LncRNA signature for prognosis prediction of patients with lung squamous cell carcinoma through tumor immune escape

in Cancer Molecular Targets and Therapeutics

Qiangqiang Ge
Zhong Lin
Xuequan Wang
Zhengli Jiang
Yan Hu

Frontiers in Oncology

doi 10.3389/fonc.2025.1511564

271 views

Original Research

Published on 24 Mar 2025

Combination of MLo-1508 with sunitinib for the experimental treatment of papillary renal cell carcinoma

in Cancer Molecular Targets and Therapeutics

Ângela Marques-Magalhães
Filipa Moreira-Silva
Inês Graça
Paula C. Dias
Margareta P. Correia
Maria Ana Alzamora
Rui Henrique
Marie Lopez
Paola B. Arimondo
Vera Miranda-Gonçalves

Frontiers in Oncology

doi 10.3389/fonc.2025.1399956

314 views

Original Research

Accepted on 21 Mar 2025

WGCNA-ML-MR Integration: Uncovering Immune-Related Genes in Prostate Cancer

in Cancer Molecular Targets and Therapeutics

Jing Lv
Yuhua Zhou
Shengkai Jin
Chaowei Fu
Bo Liu
Yang Shen
Menglu Li
Yuwei Zhang
Ninghan Feng

Frontiers in Oncology

doi 10.3389/fonc.2025.1534612

Original Research

Accepted on 20 Mar 2025

Lnc-CNNM3-DT as a Protective Factor in Cervical Cancer: Regulation of LIAS Expression and Intracellular Copper Levels

in Cancer Molecular Targets and Therapeutics

Ying Yang
Xuehong Zhu
Dan Sun
Jiangtao Fan

Frontiers in Oncology

doi 10.3389/fonc.2025.1571788

Original Research

Accepted on 20 Mar 2025

FGFR3-TACC3 fusion gene promotes glioblastoma malignant progression through the activation of STAT3 signaling pathway

in Cancer Molecular Targets and Therapeutics

Yiming Li
Jianshen Liang
Xiude Ren
Jiahe Guo
Xisen Wang
Xuya Wang
Shengping Yu
Tao Li
Xuejun Yang

Frontiers in Oncology

doi 10.3389/fonc.2025.1560008

263 views